| Molecular Diagnosis in Neonatal Hereditary Hemolytic Anemia |
December 7, 2021 |
| Regaining Revenue: How One Lab Rebuilt Its Outreach Program |
September 29, 2021 |
| Sanguine: Visual Analysis for Patient Blood Management |
June 17, 2021 |
| The Lab Must Go On |
March 3, 2021 |
| Update on the Laboratory Diagnosis of COVID-19 |
December 9, 2020 |
| Genetic Data Sharing and Reanalysis of Genomic Test Results: Challenges and Benefits to Implementation |
September 23, 2020 |
| Moving Forward from the COVID-19 Crisis: Laboratory Trends and Challenges |
June 23, 2020 |
| Laboratory Stewardship and Order Set Optimization |
March 24, 2020 |
| Rapid Antimicrobial Susceptibility Testing |
December 19, 2019 |
| Moving Beyond Single Gene-Drug Pairs in Clinical Pharmacogenomics Testing |
September 18, 2019 |
| Don’t let hospital administrators sell your lab short: A three-part webinar series on smart sourcing decisions for lab services |
May-June 2019 |
| Rapid Sequencing of Known Mendelian Genes in NICU |
March 20, 2019 |
| Genomics Reimagined in a Reference Laboratory Setting |
January 9, 2019 |
| Assessing Laboratory Performance for Next Generation Sequencing Based Detection of Germline Variants through Proficiency Testing |
September 27, 2018 |
| Laboratory Stewardship: Taking the First Steps to Downstream Savings |
June 27, 2018 |
| Novel Approaches to ID Testing Using NGS-Based Metagenomics |
March 21, 2018 |
| A Quick Guide to the Analytics Behind Genomic Testing |
December 28, 2017 |
| Sudden Cardiac Death Prevention with Molecular Diagnostics |
September 20, 2017 |
| Autoantibody Testing in the Diagnosis of Autoimmune Neurological Disorders |
June 22, 2017 |
| Human Microbiome in Health and Disease |
March 30, 2017 |
| How to Develop an Effective Utilization Management Program |
December 15, 2016 |
| Personalized Drug Therapy Is Here! An Update on Genetic Tools and Clinical Decision Support Available to Guide Drug and Dose Selection Today |
September 13, 2016 |
| Laboratory Diagnosis of Hemoglobinopathies and Thalassemia |
June 28, 2016 |
| Circulating tumor DNA: Disruptive Technology in Medicine |
March 17, 2016 |
| Next Generation Sequencing of Hematologic Neoplasms |
December 17, 2015 |
| The Changing Landscape of Hepatitis C Testing and Therapy |
September 30, 2015 |
| The Illusion of Quality: A Discussion of Roadblocks to Laboratory Quality and Case Studies of How to Make Things Better |
June 25, 2015 |
| Financial Modeling for Laboratory Decision Making |
March 19, 2015 |
| Non-Invasive Testing (NIPT) using Cell-Free Fetal DNA for Prenatal Assessment |
December 18, 2014 |
| A Hippocratic Oath for the Diagnostics Industry |
September 25, 2014 |
| Molecular Oncology: The Role of the Next Generation Sequencing-Based Gene Panels in Solid Tumors |
June 25, 2014 |
| Fitting Linear Quadrupoles and Round Flight Tubes into the Square Clinical Laboratory: The What, Where, and Why of Clinical Mass Spectrometry |
March 27, 2014 |
| Healthcare Delivery Reform and the Affordable Care Act: Current Status and Implications for Pathology & Laboratory Medicine |
December 12, 2013 |
| Applying Evidence-Based Medicine/Diagnostics to Laboratory Test Selection |
September 26, 2013 |
| Providing a More Comprehensive and Personalized Approach to Genetic Disorders through Next-Generation Sequencing |
June 18, 2013 |
| Importance of Clinical Information for Optimal Genetic Test Selection and Interpretation |
March 13, 2013 |
| Screening for Gestational Diabetes Mellitus: Challenges and Controversies |
December 27, 2012 |
| Colorectal Cancer Molecular Diagnostics |
September 12, 2012 |
| Changing Landscape of HIV Testing |
June 21, 2012 |
| The Five Macro Challenges Facing the Lab Industry |
March 22, 2012 |
| The Shifting Regulatory Sands for Clinical Laboratories |
December 15, 2011 |
| Drug Testing in the Pain Management Setting |
September 27, 2011 |
| Bacterial Identification by Mass Spectrometry |
June 29, 2011 |
| Lab Strategies in an Era of Health Care Reform |
March 14, 2011 |
Connect Sign In
